CNR1 and glioma: Furthermore, proapoptotic properties of cannabinoids are connected with an activation of either CB1 and/or CB2 receptors in some cell lines (glioma), but in other types of cell (breast, pancreatic, hepatic carcinoma) it seems to rely only on activation of CB2 receptor 15.